How I Think About Peptides in Plastic Surgery
Plastic surgery is not just an operation. It is everything that happens in the weeks before you walk into the operating room and everything you do for the months afterwards. Peptide science is an active area of research in plastic surgery, and I have integrated a structured peri-operative optimisation approach into my practice at Elyzee Hospital in Abu Dhabi for patients in whom it is clinically appropriate. This article is an educational overview, not an offer of treatment. It explains how I think about peptides as a category, what the current research suggests about compounds patients ask me about most often (including BPC-157, TB-500, GHK-Cu and Tesamorelin), and why every decision in this area is individual, made only after a full medical assessment, and only through proper medical channels.
What Peptides Are and Why They Are Discussed in Surgery
A peptide is a short chain of amino acids, the same building blocks that make up the proteins in your body. Many peptides act as signalling molecules, telling cells what to do. The peptides being studied for relevance to plastic surgery are the ones that influence wound healing, inflammation, collagen production, angiogenesis (the formation of new blood vessels) and tissue repair. A 2026 review in the Aesthetic Surgery Journal summarised the current evidence and concluded that the biological rationale is interesting, the safety signals so far are reassuring, but rigorous human clinical trials in surgical patients are still limited. That is exactly the lens through which I read this research: cautiously, individually, and never as a one-size-fits-all promise.
An important point upfront: several of the compounds discussed below are not currently licensed as medicines by the UAE Ministry of Health, the Department of Health Abu Dhabi (DOH), the FDA or other national regulators. That regulatory status shapes how, where and whether they can be discussed, sourced and considered in a clinical setting. None of what follows is a recommendation to obtain or self-administer any peptide. It is educational information about a category that is being actively studied.
The Goals I Focus on in Peri-Operative Optimisation
Before I talk about specific compounds, I want to be clear about the goals I think about for every patient I prepare for surgery. Peri-operative optimisation, with or without peptides, is built around four ideas.
1. Optimising the patient before surgery. Better metabolic health, better body composition, better skin quality and a stronger immune state going into the operating room.
2. Supporting healing in the first weeks after surgery. Faster resolution of inflammation, more robust tissue repair, better blood supply to the operated areas.
3. Improving scar quality. Calmer, flatter, less pigmented scars that mature well over the first twelve months.
4. Protecting the result long term. Stable weight, preserved lean mass, healthy skin and controlled visceral fat, so the contour I create surgically holds up over years.
Most of what gets a patient to those goals is not exotic. It is nutrition, sleep, weight stability, protein intake, scar care, sun protection, lymphatic support and a disciplined follow-up plan. Where peptides may have a role at all, it is as one possible part of that wider picture, considered case-by-case.
BPC-157 in the Research Literature
BPC-157 (Body Protection Compound 157) is a short synthetic peptide originally identified in human gastric juice. In animal research it has shown effects on the healing of skin, muscle, tendon and ligament, on angiogenesis, and on inflammation. The biology is what makes it interesting to surgeons: blood supply, tissue healing and controlled inflammation are central to every operation we perform. The caveat is also clear. BPC-157 is not licensed as a medicine in the UAE or by the FDA, the human surgical evidence is still preliminary, and any clinical conversation about it can only happen on an individual basis with appropriate medical supervision and through proper channels.
TB-500 (Thymosin Beta-4)
TB-500 is a synthetic fragment of thymosin beta-4, a peptide that occurs naturally in nearly every cell of the body. Its best-characterised role in research is in cell migration, the process by which the cells responsible for repair move into a wound, organise and rebuild tissue. Animal studies have also suggested an anti-inflammatory profile. Like BPC-157, TB-500 is not a licensed medicine in the UAE or by the FDA, and the surgical clinical evidence remains preliminary. It is one of the compounds patients sometimes raise in consultations, and where the conversation is appropriate I review the science with them honestly and on a case-by-case basis.
GHK-Cu and Skin Quality
GHK-Cu is a copper-binding tripeptide that occurs naturally in human plasma and declines with age. Of the peptides commonly discussed in this conversation, GHK-Cu has the longest history in dermatology and the most extensive published literature on skin-specific effects, including fibroblast stimulation, regulation of the enzymes that remodel the extracellular matrix, and support of hair follicle biology. Topical GHK-Cu formulations are used in some scar care protocols, alongside silicone-based therapy and disciplined sun protection. As with anything in this category, regulatory status varies by product and jurisdiction, and any clinical use is individual.
Tesamorelin and Visceral Fat
Some patients also ask about Tesamorelin, a synthetic growth hormone releasing hormone analogue that has been studied for its effect on visceral abdominal fat. Visceral fat is the deep belly fat that sits around the internal organs. It cannot be removed surgically and is a meaningful consideration in body contouring planning, because a patient with significant visceral fat will not achieve a flat abdominal contour with surgery alone. Where this category of medication is approved and available, its potential role as part of a wider pre-operative medical plan is something I will discuss with the patient and their broader medical team. As with all prescription therapies, any decision is individual, formally assessed, and made only through proper medical channels.
Peptide comparison at a glance
BPC-157. Synthetic pentadecapeptide (15 amino acids). Supports wound healing and tissue repair by promoting angiogenesis and controlling inflammation. Strong animal evidence, limited human surgical trials.
TB-500. Synthetic fragment of thymosin β4 (4 amino acid fragment). Promotes cell migration into wounds and supports scar quality through anti-inflammatory signalling. Animal and pre-clinical evidence, limited human surgical data.
GHK-Cu. Naturally occurring copper-binding tripeptide (3 amino acids plus copper). Stimulates collagen and elastin remodelling and supports skin quality, scar care and hair follicle biology. Most extensive human dermatology evidence; topical preparations widely available.
Tesamorelin. Synthetic GHRH analogue (44 amino acids). Stimulates growth hormone release and reduces visceral fat for pre-operative body composition optimisation. FDA-approved for HIV-associated lipodystrophy; off-label use in plastic surgery as a regulated prescription medicine.
Other Peptides That Come Up in the Conversation
CJC-1295 and Ipamorelin are growth hormone secretagogues that have been studied for effects on lean mass, sleep quality and recovery in selected adult populations. Regulatory status varies. Thymosin Alpha-1 is an immune-supporting peptide used clinically in some countries for specific indications. GLP-1 agonists (semaglutide, tirzepatide) are technically peptides and I see many patients on them that are seeking body contouring after GLP-1 weight loss, and is important to consider as a safety note that these medications must be paused before any procedure requiring anaesthesia.
How I Approach Preparation Before Surgery
Pre-operative optimisation is one of the most powerful and most underused tools in plastic surgery, and it does not depend on peptides. In the weeks before the operating room, I work with the patient on weight stability, protein intake, sleep, hydration, stress and any modifiable medical issues. Where a patient is interested in peri-operative regenerative strategies and where it is clinically appropriate, that conversation happens in detail at the consultation, with a full review of evidence, regulatory status, alternatives, and what is or is not available through proper medical channels. There is no template and there is no default recommendation. The plan is built around the operation, the patient and the goals.
How I Approach Recovery After Surgery
After the operation, the goal shifts to supporting healing in the first six weeks and then scar maturation over the following twelve months. Most of what decides the final result is the standard of post-operative care: protein-forward nutrition, gentle progressive movement, lymphatic drainage where appropriate, scar care that includes silicone therapy and sun protection, and a structured follow-up schedule. Where a patient and I have agreed in advance that regenerative peptide support has a role in their individual case, that plan is coordinated alongside the basics, never as a substitute for them.
Long-Term Considerations
The patients who keep the best results over five and ten years are the ones who treat surgery as one chapter of a longer health strategy. Stable weight, preserved muscle, controlled inflammation and good skin care decide how your body holds the contour I have created. For some patients ongoing medical optimisation is part of that picture. For others it is not. Any decision in this area is individual, supervised, and made against the same standard: does this measurably help this specific patient meet their goals?
Safety, Source and Medical Supervision
Two points apply universally and I cannot stress them enough.
Medical supervision is non-negotiable. Peptides influence inflammation, immune function, growth pathways, glucose metabolism and tissue repair. They can interact with other medications. Any clinical use, where lawful and available, requires individual assessment, supervision and monitoring by an appropriately qualified physician.
Source and regulatory status matter as much as the substance. The peptide market online includes products of unknown purity, often sold with disclaimers like "research chemicals not for human use", and the clinical risks of poor quality control are real, ranging from injection-site reactions to systemic infection. Several compounds discussed in this article are not licensed as medicines in the UAE or by other regulators. Nothing in this article is a recommendation to obtain or self-administer any peptide.
Is This Conversation Right for Every Patient?
No, and I want to be honest about that. Peri-operative regenerative strategies are part of a tailored, supervised plan for patients for whom a clinical assessment supports it, and only where the relevant therapies are lawful, available and appropriate. This is not a default add-on and it is not for everyone. The conversation about whether anything in this category is appropriate for you happens at the consultation, alongside the conversation about the operation itself.
Discuss Your Case at a Consultation
If you are considering plastic surgery in Abu Dhabi and you would like to understand how your preparation and recovery can be optimised, including whether peri-operative regenerative strategies may be appropriate in your specific case, I would be glad to talk it through with you. Request a consultation through my website or contact my clinic at Elyzee Hospital in Abu Dhabi directly. At your consultation I will review your medical history, assess your specific goals, explain the surgical options, and discuss the full peri-operative plan that fits your individual case.
